Zuhlke Ventures
Corporate Venture CapitalSchlieren, SwitzerlandSee on the map
Zühlke Ventures is the venture capital arm of Zühlke, a technology and consulting organisation. It provides early-stage financing exclusively to HealthTech startups.
- 2
- Portfolio companies on reccy
- 0
- Hiring now
- 0
- Open roles in the portfolio
- Dec 2022
- Latest portfolio round
Hiring now in the portfolio0
Apply on each company's siteNone of their companies on reccy has an open role right now. Browse all neurotech roles
Portfolio on reccy2
From company funding recordsTheir companies, round by round
From company funding records- BottneuroBasel, Switzerland
Neuromodulation
- Apr 2026Grant
- Jan 2024Early Stage VC · $1.6M
- Dec 2022Venture Round
- Dec 2022Series A
- Dec 2022Convertible Note · $4.3MLed
- Dec 2022Seed · $6.5M
- Flow NeuroscienceMalmö, Sweden
Neuromodulation · Wearables
- Feb 2026Venture Round
- Oct 2025Accelerator/Incubator · $13M
- Jul 2024Convertible Note · $13M
- Jun 2023Non-Equity Assistance
- Aug 2021Series A · $10MLed
- May 2021Seed
Rounds marked Led list Zuhlke Ventures as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
- Dec 2022
Bottneuro · Convertible Note $4.3MLead
With HEMEX, DART Labs I Ventures
- Aug 2021
Flow Neuroscience · Series A $10MLead
With Khosla Ventures, Redstone.VC, SwissHealth Ventures, Global Brain Corporation, Schox Patent Group, Kirin Holdings Company, Limited, SOSV, HAX
- Undated
Bottneuro · Convertible NoteLead
Portfolio in the news
From the Cortex · last 12 months- Sep 2026
- Sep 2026The Device Is the Easy Part
Flow Neuroscience · NeuroTechX Content Lab - Medium
- Apr 2026
- Dec 2025FDA Approves First At-Home Brain Stimulation Treatment for Depression
Flow Neuroscience · technologynetworks.com
- Dec 2025
- Dec 2025FDA Approves World’s First At-Home Brain Stimulation for Depression
Flow Neuroscience · flowneuroscience.com